Systematic review and meta-analysis of efficacy and safety of combinational therapy with metformin and dipeptidyl peptidase-4 inhibitors

Combinational therapies are often required in the management of type 2 diabetes mellitus (T2DM). Among the important candidates, dipeptidyl peptidase-4 inhibitors (DPPIs) and metformin combination (DPPI-MET) have shown promising endeavors. In order to examine the efficacy and safety of such a combin...

Descripción completa

Detalles Bibliográficos
Autor principal: Alanazi, Abdulrahman S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669429/
https://www.ncbi.nlm.nih.gov/pubmed/26702254
http://dx.doi.org/10.1016/j.jsps.2013.12.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669429/
https://www.ncbi.nlm.nih.gov/pubmed/26702254
http://dx.doi.org/10.1016/j.jsps.2013.12.018

Ejemplares similares